Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021

SELL
$46.35 - $59.75 $186,790 - $240,792
-4,030 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$47.2 - $67.81 $190,216 - $273,274
4,030 New
4,030 $212,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.